STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
349
13F, latest reported quarter
Conversions, 180 days
25
Codes C/M, not in net · $35.0M priced
What the filings say about GL
Insiders, 180 days
-$56.5M net sold
10 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-07-10
Planned sales (Form 144), 90 days
$20.3M
5 notices
Globe Life insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, GLOBE LIFE INC. insiders sold a net $56.5M of stock across 234 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Mar 2, 2026.
The trade is 17.6% of the 19,039 shares held after it.
No other insider sold within 30 days.
349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Chief Investment Officer Hensley Robert Edward sold about $566.9K of GL on Sep 22, 2026; 349 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Mar 2, 2026.
The trade is 53.7% of the 12,383 shares held after it.
No other insider sold within 30 days.
349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Chief Investment Officer Hensley Robert Edward sold about $1.1M of GL on Sep 22, 2026; 349 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on May 29, 2026.
The trade is 58.7% of the 19,526 shares held after it.
3 other insiders sold within 30 days.
349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, General Counsel and CRO MITCHELL ROBERT BRIAN sold about $2.1M of GL on Aug 7, 2026; 3 other insiders sold within 30 days and 349 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on May 29, 2026.
The trade is 117.0% of the 8,997 shares held after it.
3 other insiders sold within 30 days.
349 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, General Counsel and CRO MITCHELL ROBERT BRIAN sold about $1.9M of GL on Aug 7, 2026; 3 other insiders sold within 30 days and 349 funds added in the latest 13F quarter.
234 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
GL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Michael C. Majors
Filed 2026-10-26
$2.4M
Robert E. Hensley
Filed 2026-09-22
$1.7M
Frank M. Svoboda
Filed 2026-08-13
$2.9M
MITCHELL ROBERT BRIAN
Filed 2026-08-05
$4.2M
James Matt Darden
Filed 2026-07-29
$9.0M
GL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Victory RS Investors Fund
$4.7M position · as of 2026-06-30
6.7%
SEGALL BRYANT & HAMILL SELECT EQUITY ETF
$16.2M position · as of 2026-06-30
4.5%
Victory RS Value Fund
$11.2M position · as of 2026-06-30
4.4%
Victory RS Partners Fund
$23.6M position · as of 2026-06-30
3.5%
Hartford Global Impact Fund
$10.8M position · as of 2026-07-31
3.0%
SBH GLOBAL ALL CAP FUND
$1.0M position · as of 2026-06-30
2.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Globe Life Inc. Pac
Cycle 2026 · $69K spent
$86.7K
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $56.5M sold by insiders over 180 days, 349 funds added last quarter, $20.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GL
FY Dec 2025
$6.0B
FY Dec 2024
$5.8B
FY Dec 2023
$5.4B
FY Dec 2022
$5.2B
FY Dec 2021
$5.1B
Jun 2026
$1.6B
Mar 2026
$1.6B
Dec 2025
$1.5B
Sep 2025
$1.5B
Jun 2025
$1.5B
Mar 2025
$1.5B
Dec 2024
$1.5B
Sep 2024
$1.5B
At each fiscal year end
Single quarter
Net margin, TTM
+19.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GL
FY Dec 2025
+19.4%
FY Dec 2024
+18.5%
FY Dec 2023
+17.8%
FY Dec 2022
+17.1%
FY Dec 2021
+20.2%
Jun 2026
+18.0%
Mar 2026
+17.3%
Dec 2025
+17.5%
Sep 2025
+25.6%
Jun 2025
+17.1%
Mar 2025
+17.2%
Dec 2024
+17.4%
Sep 2024
+20.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.2B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GL
FY Dec 2025
$1.3B
FY Dec 2024
$1.3B
FY Dec 2023
$1.4B
FY Dec 2022
$1.4B
FY Dec 2021
$1.4B
Jun 2026
$297.6M
Mar 2026
$396.0M
Dec 2025
$330.1M
Sep 2025
$208.7M
Jun 2025
$295.0M
Mar 2025
$420.1M
Dec 2024
$321.9M
Sep 2024
$311.3M
At each fiscal year end
Single quarter
Debt to equity
0.48x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity GL
FY Dec 2025
0.44x
FY Dec 2024
0.52x
FY Dec 2023
0.36x
FY Dec 2022
0.45x
FY Dec 2021
0.85x
Jun 2026
0.48x
Mar 2026
0.46x
Dec 2025
0.44x
Sep 2025
0.48x
Jun 2025
0.51x
Mar 2025
0.52x
Dec 2024
0.52x
Sep 2024
0.60x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.47x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt GL
FY Dec 2025
0.53x
FY Dec 2024
0.51x
FY Dec 2023
0.91x
FY Dec 2022
0.79x
FY Dec 2021
0.85x
Jun 2026
0.47x
Mar 2026
0.50x
Dec 2025
0.53x
Sep 2025
0.51x
Jun 2025
0.51x
Mar 2025
0.53x
Dec 2024
0.51x
Sep 2024
0.53x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+20.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GL
FY Dec 2025
+20.6%
FY Dec 2024
+21.9%
FY Dec 2023
+23.0%
FY Dec 2022
+30.0%
FY Dec 2021
+70.2%
Jun 2026
+20.9%
Mar 2026
+20.5%
Dec 2025
+20.6%
Sep 2025
+22.3%
Jun 2025
+20.0%
Mar 2025
+20.5%
Dec 2024
+21.9%
Sep 2024
+23.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GL
FY Dec 2025
+3.9%
FY Dec 2024
+3.7%
FY Dec 2023
+3.6%
FY Dec 2022
+3.2%
FY Dec 2021
+3.5%
Jun 2026
+4.0%
Mar 2026
+3.9%
Dec 2025
+3.9%
Sep 2025
+3.8%
Jun 2025
+3.7%
Mar 2025
+3.7%
Dec 2024
+3.7%
Sep 2024
+3.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.8%
operating income after a 18.9% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital GL
FY Dec 2025
+13.5%
FY Dec 2024
+14.6%
FY Dec 2023
+17.6%
FY Dec 2022
+20.2%
FY Dec 2021
+31.4%
Jun 2026
+12.8%
Mar 2026
+13.1%
Dec 2025
+13.5%
Sep 2025
+14.2%
Jun 2025
+13.7%
Mar 2025
+13.8%
Dec 2024
+14.6%
Sep 2024
+15.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed GL
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.27x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GL
FY Dec 2025
9.93x
FY Dec 2024
9.33x
FY Dec 2023
12.08x
FY Dec 2022
13.35x
FY Dec 2021
9.38x
Jun 2026
11.86x
Mar 2026
9.62x
Dec 2025
9.93x
Sep 2025
10.36x
Jun 2025
9.94x
Mar 2025
10.72x
Dec 2024
9.33x
Sep 2024
8.96x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value GL
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.4%
TTM free cash flow over market value at close 2026-10-23
FCF yield GL
FY Dec 2025
+11.3%
FY Dec 2024
+14.2%
FY Dec 2023
+12.5%
FY Dec 2022
+11.9%
FY Dec 2021
+14.8%
Jun 2026
+8.9%
Mar 2026
+11.2%
Dec 2025
+11.3%
Sep 2025
+10.8%
Jun 2025
+13.1%
Mar 2025
+12.8%
Dec 2024
+14.2%
Sep 2024
+14.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.50x
P/E over trailing EPS growth of 20%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing GL
FY Dec 2025
0.55x
FY Dec 2024
0.50x
FY Dec 2023
1.04x
FY Dec 2022
n/a
FY Dec 2021
0.20x
Jun 2026
0.58x
Mar 2026
0.54x
Dec 2025
0.55x
Sep 2025
0.62x
Jun 2025
0.76x
Mar 2025
0.62x
Dec 2024
0.50x
Sep 2024
0.40x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GL ranks highest on profitability (61st percentile) and risk and compliance (58th), and lowest on insider conviction (5th), among Insurance peers.
Profitability
61
Inputs
Return on equity+20.9% · 71 pct, sector of 116
Return on assets+4.0% · 59 pct, sector of 122
Return on invested capital+12.8% · 54 pct, universe of 1,069
Return on capital employedassets or current liabilities not filed
Financial health
36
Inputs
Debt to equity0.48x · 28 pct, sector of 104
Cash flow to debt0.47x · 44 pct, sector of 97
Growth
31
Inputs
Revenue growth, YoY+3.7% · 31 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
5
Inputs
Net Form 4 buying (codes P and S), 180d-$56.5M · 9 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
53
Inputs
Funds adding, latest quarter349 · 78 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$240K · 29 pct, sector of 35
Risk and compliance
58
Inputs
Short interest, % of float+2.8% · 63 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+9.9% · 54 pct, sector of 110
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GL filings, in plain words
Are Globe Life insiders buying or selling GL?
In the 180 days to 2026-10-27, Globe Life insiders were net sellers, a net $56.5M across purchases and sales reported on Form 4, by 10 sellers.
Have members of Congress traded GL?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Lisa McClain dated 2025-07-10.
Are there planned insider sales of GL?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $20.3M of stock; the latest, by Michael C. Majors, was filed 2026-10-26.
Read the full summary
In the 180 days to 2026-10-27, Globe Life insiders were net sellers of GL, a net $56.5M across purchases and sales reported on Form 4 by 10 sellers. None of the 49 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in GL, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-07-10. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $20.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.